Teva Files Ninth Suit Over Heart Failure Drug
Teva Pharmaceutical Industries Ltd. has gone on the warpath ahead of the anticipated expiration of GlaxoSmithKline's pediatric exclusivity period for its congestive heart failure treatment Coreg, filing nine patent suits in...To view the full article, register now.
Already a subscriber? Click here to view full article